The benefits of innovation in the Animal Health Industry

1
The benefits of innovation in the Animal Health
Industry

• Technology platform - a global strategic
  research agenda for animal health.
• Brussels
• 28 June 2006

Jim Scudamore Liverpool University and ETPGAH
Consultant.
2
Outline of the presentation

• Setting the Scene
• The European Technology Platform for Global
  Animal Health
• The Vision
• The Strategic Research Agenda
• Implementation of the Strategic Research Agenda
• Conclusion

3
European Technology Platforms What are ETPs?

• Novel instrument of the ERA policy in areas of
  high technological potential to
• Strengthen European research and innovation and
  ensure European competitiveness
• Articulate coherent long term research policies
  representing a consensus between all stakeholders
  
• Mobilise a critical mass of European, national
  and
• regional resources comprising both public and
  private financing

4
European Technology Platforms Central Concept

• Framework to unite stakeholders around
• a common vision for the technology concerned.
  Long term
• definition of a Strategic Research Agenda to
  deliver the vision
• Consultation to implement the plan

5
European Technology Platforms Approach

• Wide stakeholder base
• - industry, public authorities, research
  community, financial institutions, regulators,
  civil society and consumers
• Mobilisation of public and private funding
• - Community Framework Programmes, Structural
  Funds, national, regional and private research
  funding, EIB, EUREKA
• Education, training, communication, dissemination

6
Outline of the presentation

• Setting the Scene
• The European Technology Platform for Global
  Animal Health
• The Vision
• The Strategic Research Agenda
• Implementation of the Strategic Research Agenda
• Conclusion

7
European Technology Platforms Why for Animal
Health?

• A Global Problem
• Worldwide risks
• Impact of animal disease in
• developed and developing
• Control Measures- inadequate
• Vaccines, pharmaceuticals and diagnostics only

8
Source European Research Advisory Board report
on TPs Jan 2004
9
European Technology Platform for Global Animal
Health How does it work?
Stakeholders, led by industry, come together
to agree on a common vision for the technology
Stakeholders, define a Strategic Research
Agenda setting the necessary mid- to longterm
objectives
Stakeholders, implement the Strategic
Research Agenda with the mobilisation of
significant human and financial resources
10
European Technology Platform for Global Animal
HealthWhere are we now?
Stakeholders, led by industry, come together
to agree on a common vision for the technology
Stakeholders, define a Strategic Research
Agenda setting the necessary mid- to longterm
objectives
Stakeholders, implement the Strategic
Research Agenda with the mobilisation of
significant human and financial resources
Implementation Plan detailed, roadmap,
quantify, identify funding sources creation of a
financial working group Launch late 2006
Vision paper EU TP Global Animal Health
Final version August 2005
Strategic Research Agenda Published May 2006
11
ETP Global Animal HealthOutline of the
presentation

• Setting the scene
• The European Technology Platform for Global
  Animal Health
• The Vision
• The Strategic Research Agenda
• Implementation of the Strategic Research Agenda
• Conclusion

12
ETP Global Animal HealthThe Vision
Developed by a group of representatives from the
different stakeholders Industry Animal Health,
Biotech, Agriculture Academia Veterinary
Organisations Farmers organizations Consumer
organizations Experts in regulatory issues The
ETPGAH presents Long term vision for the control
of animal diseases of major importance.
Published August 2005
13
ETP Global Animal HealthThe Vision Aim

• To facilitate and accelerate the development and
  distribution of the most effective tools for
  controlling animal diseases of major importance
  to Europe and the rest of the world, thereby
  improving human and animal health, food safety
  and quality, animal welfare, and market access,
  contributing to achieving the Millennium
  Development Goals.

14
ETP Global Animal HealthThe Vision Scope

• MUMS,
• Parasite resistance,
• Bacterial resistance
• Terrestrial animals
• Importance of endemic disease
• Alternative approaches for control
• Importance of pharmaceuticals

15
ETP Global Animal HealthThe Vision Objectives

• Protect Europe from the incursion of epidemic
  animal diseases and zoonoses.
• Deal rapidly and effectively with outbreaks in
  Europe should they occur.
• Assist in speed of access to market, facilitation
  of world trade and the alleviation of poverty by
  reducing the impact of these diseases in
  developing countries.
• Reduce worldwide levels of disease and thereby
  indirectly protect Europe from disease spread by
  people or trade.

16
ETP Global Animal HealthOutline of the
presentation

• Setting the scene
• The European Technology Platform for Global
  Animal Health
• The Vision
• The Strategic Research Agenda
• Implementation of the Strategic Research Agenda
• Conclusion

17
ETP Global Animal HealthDeveloping the SRA

• Following publication of the interim Vision
  Paper, the Steering Council of the ETPGFAH
  decided that 3 workshops should be held to
  address the key issues
• Sought wide spectrum participation of
  stakeholders 20 for each
• Held three 1 day workshops in October and again
  in November 2005 one on each key subject area
• Had designated chairpersons from Steering
  Council

Published May 2006
18
Method to develop SRA
Method to develop SRA Challenges
To discuss
Strategic Research Agenda

Basic research
WG 1
Technology transfer
WG 2
Securing a healthy and safe food supply
Competitiveness and consumer choice
Public Health
Sustainable agriculture

Horizontal issues
WG 3
Vision Global Animal Health
Challenges taken from Global Animal Health
3 Views to address the challenges.
Acknowledgement Plants for life platform
19
ETP Global Animal HealthThe SRA Six Themes

• Strategically important issues
• High societal relevance
• Linked to Europes future growth,
  competitiveness, and sustainability
• Dependant upon major research and
  technological advances
• Medium to long-term scope
• Important consequences for animal health
  research
• Aligned with other Community policies and
  strategies
• Significance for developing world

1 Prioritise animal diseases
5 Regulatory Societal Issues
2 Gap Analysis
3 Fundamental research
4 Improve Technology Transfer
6 Global Perspective
SRA
Finalised and submitted to the EU Commission in
May 2006
20
ETP Global Animal HealthThe SRA Six Themes

• Quality Assurance
• Intellectual property rights
• Overcome barriers Proof of concept
• Networks of excellence
• Education and Training
• Infrastructure

Technology transfer
1 Prioritise animal diseases
5 Regulatory Societal Issues
2 Gap Analysis
3 Fundamental research
4 Enabling Factors
6 Global Perspective
SRA
Finalised and submitted to the EU Commission in
May 2006
21
ETP Global Animal HealthSRA Main deliverables.

• bring more focus into research towards new tools
  for dealing with animal diseases.
• increase the translation of technology into
  applications, which areefficacious in the
  control of animal disease.
• bring the developed tools faster to the market.
• remove unnecessary legal and regulatory hurdles,
  which limit diseasecontrol options and decrease
  competitiveness of the industry.
• enable disease control authorities both within
  the EU and other countries to provide a swift and
  efficient reaction to new disease outbreaks.
• streamline research, development and regulatory
  efforts in order to ensureconsumer safety
  without compromising the efficiency of the
  productdevelopment.
• view projects in the context of feasibility,
  applicability, need and availability of existing
  products within the time frame of the SRA.

22
ETP Global Animal HealthOutline of the
presentation

• Setting the scene
• The European Technology Platform for Global
  Animal Health
• The vision
• The Strategic Research Agenda
• Implementation of the Strategic Research Agenda
• Conclusion

23
ETP Global Animal HealthImplementation of the SRA
Next stage
24
ETP Global Animal HealthImplementation of the SRA

• SRA Provides a Roadmap
• Research Requirements
• Actions to achieve Aims not all research
• Six Themes
• Recommendations Identified
• Now Identify Deliverables
• Collaboration is Critical
• Efficient Use of Resources
• Better Case for Funding

25
ETP Global Animal HealthImplementation of the SRA

• Establish Costs of Research
• Establish Timelines for Research
• Who should carry out Research?
• Who should Fund Research?
• Need to conduct Research on Disease
  Prioritisation Model (Chapter 2) as first step
• Need to complete Gap Analysis (Chapter 3) as
  second step

26
ETP Global Animal HealthImplementation of the SRA

• Priority 1 targets that are achievable in the
  short-mid term
• Priority 2 targets that are potentially
  achievable in the mid-long term (brucellosis,
  tuberculosis, some antiparasitic vaccines, oral
  vaccination (for selected targets)
• Priority 3  Ideal World Projects  (Long-term)
  parasite vaccines, mastitis vaccines, food safety
  vaccines

27
Implementation of the SRA Potential Funders
28
Implementation of the SRA Links to EU Funding

Framework 7 Programme 2007 to 2013
Cooperation Collaborative research 32.342b
(1.944)
Ideas Frontier Research 7.460b
People Human Potential 4.728b
Capacities Research Capacity 4.243b

• Cooperation is 64 of budget of FP 7 budget of
  50.524 billion
• Food, Agriculture Biotech - 1.944b

29
ETP Global Animal HealthImplementation of the SRA

• Future EC Programs (e.g. FP7)
• Close consultation with EC, MSs, EP
  representatives
• Future national research programs
• Providing opportunities to better align and
  coordinate national programs. (ERA-Net)
• Public/private research partnerships
• Exploring areas of strategic importance in which
  ambitious initiatives can be taken

30
ETP Global Animal HealthOutline of the
presentation

• Setting the scene
• The European Technology Platform for Global
  Animal Health
• The vision
• The Strategic Research Agenda
• Implementation of the Strategic Research Agenda
• Conclusions

31
ETP Global Animal Health Conclusions Innovation
Who and how?
Major industry Players
Research Centers
Discovery
Preclinical Development
Clinical Development
Manufacture
Registration
Sales
32
ETP Global Animal Health Conclusions The
Organisation
33
ETP Global Animal Health Conclusions The
Stakeholders

• European Associations relevant to Animal Health
  and Welfare and Food Safety
• IFAH-Europe, COPA-COGECA (farming industry),
  EuropaBio, Diagnostics,
• FVE (Veterinarians), Consumers (BEUC), Eurogroup
  Animal Welfare
• International organizations relevant to Animal
  Health and Welfare and Food Research
  Organizations
• e.g. OIE, FAO, WHO, ILRI, GALV
• European Regulatory Authorities
• Heads of Agencies, EMEA, EDQM
• Representatives from the European Research
  Community
• Universities, Institutes, Network of Reference
  Laboratories
• Member State Representations
• CVOs
• European Institutions
• EFSA, European Commission (DG Research, DG SANCO,
  DG Development, DG Enterprise)

34
Presentation of the SRA to the Commissioner on 19
May
35
ETP Global Animal Health Conclusions

• Action Plan to be produced following
  consultations with stakeholders and member states
  authorities. These will complement the vision
  document and the SRA.
• Identify funding sources for the implementation
  of the SRA. This will involve meetings with
  international funders and with the funding
  authorities in the EU and the member states.
• The recommendations in the SRA will need to be
  discussed with all stakeholders to identify who
  will have responsibility and ownership of the
  different components of the SRA.

36
ETP Global Animal Health Conclusions

• Once the gap analyses have commenced the results
  will need to be reviewed by the platform in order
  to identify and make recommendations to develop
  specific diseases, technology and science
  programmes to fill the gaps.
• Once the Action Plan is completed and agreed with
  stakeholders the platform will be responsible for
  monitoring progress and undertaking an annual
  review of activities.

37
ETP Global Animal HealthUseful links for
information

• CORDIS Web Site
• http//cordis.europa.eu.int/technology-platforms/h
  ome_en.html
• CORDIS partner search http//fp6.cordis.lu/fp6/pa
  rtners.cfm
• Seventh Framework Programmehttp//europa.eu.int/
  comm/research/future/index en.cfm
• IFAH Global Animal Health Platform
• www.ifah.be/europe/euplatform/platform.htm